Supernus Pharmaceuticals Reveals Exciting Conference Engagements
Supernus Pharmaceuticals Announces Participation in Investor Conferences
Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a prominent player in the biopharmaceutical sector, is dedicated to innovating treatments for central nervous system (CNS) disorders. The company has announced that its President and CEO, Jack Khattar, will take part in important investor conferences designed to foster engagement and provide insights into future developments.
Key Investor Conferences This March
During the month of March, Supernus will feature prominently in two major conferences where Jack Khattar will present.
Barclays Global Healthcare Conference
On March 11, 2025, Khattar will participate in a fireside chat scheduled for 12:30 p.m. ET at the renowned Barclays Global Healthcare Conference, which will be hosted at the Loews Miami Beach Hotel. This platform will offer an excellent opportunity for investors to hear directly from the company’s leadership about its strategic direction and product developments.
Jefferies Biotech on the Beach Summit
The very next day, on March 12, 2025, he will continue to engage audiences at the Jefferies Biotech on the Beach Summit at the Ritz-Carlton South Beach. This event is anticipated to attract a significant number of industry leaders and investors, providing Supernus an avenue to highlight its groundbreaking initiatives.
Investor Engagement Opportunities
Investors interested in discussions with Supernus management during these events are encouraged to reach out to the respective conference coordinators. Facilitating these conversations highlights Supernus’ commitment to transparency and investor relations.
Fireside Chat Webcast Information
A live audio webcast of Khattar’s discussion at the Barclays Global Healthcare Conference will be accessible to those unable to attend in person. Participants can view the webcast on the Supernus website, under the Events & Presentations section, ensuring that investors have comprehensive access to the insights shared. An archived version of this conference will be available for an extended period following the event, further extending access to vital information.
About Supernus Pharmaceuticals
Supernus Pharmaceuticals stands at the forefront of developing innovative therapies aimed at improving the lives of individuals suffering from CNS conditions. The company boasts a diverse portfolio of approved treatments addressing ADHD, dyskinesia in Parkinson’s patients, epilepsy, and various other serious conditions.
In addition to its current offerings, Supernus is actively engaged in the development of new products designed for epilepsy, depression, and additional CNS disorders. This forward-thinking approach underlines its mission to expand therapeutic options available to patients.
Contact Information
For further inquiries about Supernus Pharmaceuticals or the upcoming conferences, interested parties are welcome to connect with Jack A. Khattar, President and CEO, or Timothy C. Dec, Senior Vice President and CFO, at (301) 838-2591. The company is poised to engage with the investment community and address any inquiries regarding their innovative approach to CNS treatment.
For investor communications, Peter Vozzo from ICR Healthcare can be contacted at (443) 213-0505 or via email at peter.vozzo@icrhealthcare.com.
Frequently Asked Questions
What is the significance of the Barclays Global Healthcare Conference for Supernus?
This conference is an opportunity for Jack Khattar to engage with investors and present updates on Supernus’ strategies and product innovations.
Which products are currently being developed by Supernus Pharmaceuticals?
Supernus is focused on a broad range of CNS disorders, with treatments for ADHD, Parkinson’s disease, epilepsy, and more under exploration.
How can investors connect with Supernus during these conferences?
Investors are encouraged to reach out to conference coordinators for opportunities to meet with Supernus management amid the events.
Will the webcast of the fireside chat be accessible later?
Yes, an archived version of the fireside chat will be available for viewing on the Supernus website for 60 days following the conference.
Who can I contact for more information about Supernus?
For inquiries, you can reach out to Jack A. Khattar or Peter Vozzo using the provided contact information.
About The Author
Contact Henry Turner privately here. Or send an email with ATTN: Henry Turner as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.